Figure 1
Body weight changes in an eight-week trial of DOV 21,947 in healthy subjects
Change in body weight at study end point (left panel) and at one-week post-treatment (right panel) are shown. (ANCOVA among
the three study groups; body weight at baseline and gender were applied as covariates. ap<0.0055 vs placebo; bp<0.0019 vs noncompliant; cp<0.044 vs noncompliant).